we asked the mhra, the organisation who is meant to police this, and they told us... about how apetamin affects people. i am about to skype call doctor victoria, she is in america, she wrote this paper. this is one of the few studies done on apetamin. hello. nice to meet you. my first question is, when did you first find out about apetamin? i had a patient who came into our liver clinic and she was complaining of fatigue. she was jaundiced, her skin was yellow. her body was fighting her liver. do you know how serious it could have been if she was to perhaps continue taking it? it is hard to know what would have happened, she could have full liver failure had she continued. yeah, because when my mother was taking it, she was kind of like the patient you just described, you just described, she was taking a lot, she was over the limit. it actually caused her to go coma. i am really sorry to hear that. what particularly worries me about apetamin is the way that it is marketed. as a vitamin supplement, which implies it is safe, that it is natural. the active ingredient tha

-- mhra.e teesside vaccine as he calls it, the novavax vaccine. but he is also right to raise the point of the vaccinations around the world. this is a critical role the uk can be very proud of having played. because of the investment we made in the oxford astrazeneca vaccine, right at the start of this pandemic, and because of the way that a long with oxford university and astrazeneca, we have decided together to make this vaccine available at cost around the world and i can tell the house with an update that there have now been over 450 million doses of the oxford astrazeneca vaccine deployed around the world at cost. that is the single biggest gift to the world that we could make with respect to vaccines. it is because of the attitude that this government took working with one of our greatest universities, working with one of a greatest industrial partners, it�*s another example of the big team effort that is helping, in this case, the whole world to get out of this pandemic. in a in this c

basically, we will have the mhra, the medical regulator, saying they do not think the overall risk hasjcvi, the expert advise anybody who says, in the light of the medical safety advice, how do you carry on with the role that? essentially, it has a balance of risks and visibility of other vaccines because there is enough pfizer and moderna, they can switch the under a0s to those as they have already done for the under 30s. and because the virus is not spending nearly as rapidly as it was, they risk there has fallen. so it is trying to balance all of those things and say, the risk remains extremely low. with astrazeneca, but basically, these other vaccines will be on offer. it has a complex picture and it may be a bit difficult for everyone to grasp, but it is just balancing all of those different factors, which is what they have come up with today. yes. a very interesting _ they have come up with today. yes. a very interesting to _ they have come up with today. yes. a very interesting to listen _ they have come up with today. yes. a very interesting to listen to. - they have come up wi

so we will have to see what the mhra decides, _ we will have to see what the mhra decides, and they wille sorts of patterns emerging again and again in different ages, between the two sexes, etc, you can begin to make some kind of inference about what might be a genuine side effect versus a coincidence. but it seems to be quite variable. the only real strong trend we have seen it at the side effects tend to be with increasing age, and they tend to be fewer with the second dose compared to the first dose of the vaccines. but everyone is an individual, everyone responds a bit differently, and the evidence we do have is that if you do or don't have side effects, that does not have a bearing on your response to the vaccine, and you shouldn't read into the fact that perhaps you haven't had side effects that you are not immune, that isn't the case. hind immune, that isn't the case. and with things _ immune, that isn't the case. fific with things opening up at the moment, could it be that we have been separated for so long, if we pick up a different bug at the moment, things are feeling a lot wo

data release there has been just about _ from the data release there has been just about 240 at the mhra figures show us and it shows there is a risk below the - the figures show us and it shows there is a risk below the age - the figures show us and it shows there is a risk below the age of. the figures show us and it shows i there is a risk below the age of 40 and since — there is a risk below the age of 40 and since we — there is a risk below the age of 40 and since we have _ there is a risk below the age of 40 and since we have alternatives, i there is a risk below the age of 40 i and since we have alternatives, why not just _ and since we have alternatives, why not just switch — and since we have alternatives, why not just switch to _ and since we have alternatives, why not just switch to one _ and since we have alternatives, why not just switch to one of— and since we have alternatives, why not just switch to one of those - and since we have alternatives, why not just switch to one of those for. not just switch to one of those for those _ not just switch to one of those for those o